INVUS
Invus recognizes that every company is unique and that extraordinary business performance cannot be achieved by following a formulaic approach. Due to their unique structure, they have a great deal of flexibility in the types of companies and situations where they can get involved. Perhaps most importantly, they know that real transformation takes time and that it’s never a straight line. They fully align their incentives with their partners and have the wherewithal and long-term commi... tment to see through any bumps along the way. They have been successfully empowering owner-managers since 1985. They have been reinvesting the same pool of money from the same group of European families (through their Artal investment vehicle) since their founding. Today they manage over $4 billion in an evergreen fund and work out of offices in New York, London, Paris and Hong Kong.
INVUS
Social Links:
Industry:
Application Performance Management Business Development Finance
Founded:
1985-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.invus.com
Total Employee:
51+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Domain Not Resolving Euro Microsoft Microsoft Azure Microsoft Azure US East Region 3 To 9 CcTLD Redirects DocuSign Network Solutions
Similar Organizations
Khosla Ventures
Khosla Ventures is a venture capital firm that focuses on environmentally friendly tech, internet, computing, mobile, and silicon tech.
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2016-06-06 | Ashley Stewart | Ashley Stewart acquired by Invus | N/A |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-09-08 | Autobahn Therapeutics | Invus investment in Venture Round - Autobahn Therapeutics | 32.7 M USD |
| 2022-09-02 | Abivax | Invus investment in Post-IPO Equity - Abivax | 49.2 M EUR |
| 2022-08-02 | Sironax | Invus investment in Series B - Sironax | 200 M USD |
| 2022-07-28 | Lexicon Pharmaceuticals | Invus investment in Post-IPO Equity - Lexicon Pharmaceuticals | N/A |
| 2022-07-27 | AlloVir | Invus investment in Post-IPO Equity - AlloVir | 126.6 M USD |
| 2022-07-13 | Gossamer Bio | Invus investment in Post-IPO Equity - Gossamer Bio | 120 M USD |
| 2022-07-12 | Vascular Dynamics | Invus investment in Venture Round - Vascular Dynamics | 20 M USD |
| 2022-06-17 | Scholar Rock | Invus investment in Post-IPO Equity - Scholar Rock | 205 M USD |
| 2022-06-16 | HappyVore | Invus investment in Funding Round - HappyVore | 35 M EUR |
| 2022-06-13 | ImCheck Therapeutics | Invus investment in Series C - ImCheck Therapeutics | 96 M EUR |
Official Site Inspections
http://www.invus.com Semrush global rank: 2.73 M Semrush visits lastest month: 6 K
- Host name: 67.225.188.255
- IP address: 67.225.188.255
- Location: Lansing United States
- Latitude: 42.7348
- Longitude: -84.6245
- Metro Code: 551
- Timezone: America/Detroit
- Postal: 48917
